Axsome Therapeutics (AXSM) Misses Q4 EPS by 58c

Axsome Therapeutics (NASDAQ: AXSM) reported Q4 EPS of ($1.54), $0.58 worse than the analyst estimate of ($0.96). Revenue for the quarter came in at $117.32 million versus the consensus estimate of $117.69 million.

For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• BuzzFeed sells shares to Byron Allen affiliate for $5.8 million
• KeyCorp (KEY) files for 158.72M share offering by selling stockholders